Opioid Use Disorder Increases 30-Day Readmission Risk in Inflammatory Bowel Disease Hospitalizations: a Nationwide Matched Analysis

Related medical research illustration

Overview

Nationwide matched analysis investigating opioid use disorder and 30-day readmission risk in IBD hospitalizations.

Publication Details

**Journal:** Journal of Crohn's and Colitis

**Year:** 2020

**Authors:** Charilaou P, Mohapatra S, Joshi T, Devani K, Gadiparthi C, Pitchumoni CS, Goldstein D

**PMID:** 31804682

**DOI:** 10.1093/ecco-jcc/jjz198

Key Findings

This publication contributes to the field of gastroenterology and hepatology, providing valuable insights into gastroenterology and hepatology. The research methodology and findings offer important implications for clinical practice and patient care.

Clinical Significance

The findings from this study have significant implications for:

- Clinical decision-making in gastroenterology

- Patient care and treatment protocols

- Future research directions in the field

Access the Full Publication

For the complete research article, detailed methodology, and comprehensive results, please refer to the original publication.

This blog post summarizes a peer-reviewed publication by Dr. Kalpit Devani and colleagues. For detailed information, please refer to the original publication.